Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nematode muscle nicotinic acetylcholine receptor (nAChR) is a pentameric ligand-gated ion channel essential for excitatory neurotransmission at the nematode neuromuscular junction (Martin et al., 2012, PubMed). It is a primary target for anthelmintic drugs, which often exploit the receptor's open channel state to induce paralysis in parasitic worms. Agonists like levamisole and pyrantel bind to the receptor, causing the channel to open and remain in a persistent active state, leading to depolarization block and spastic paralysis (Robertson et al., 2013, PubMed). Conversely, some antagonists or pore-blockers specifically target the open conformation to inhibit ion flow. This receptor is composed of various subunits, such as UNC-38 and UNC-29, which provide the structural basis for its cation selectivity (UniProt). Because these receptors differ significantly from mammalian subtypes, they offer a high degree of therapeutic selectivity for treating helminth infections (Wolstenholme, 2011, PubMed). Understanding the transition to the open channel state is crucial for developing new drugs that can overcome resistance in species like Haemonchus contortus.
Agonist-induced persistent activation leading to spastic paralysis; Open-channel blockade; Competitive antagonism.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nematode muscle nicotinic acetylcholine receptor (nAChR).